U.S. Patent Granted
June 9th 2020, the United States Patent and Trademark office (USPTO) announced that Particle3D’s patent, Feedstock for 3D printing and uses thereof no. PCT/DK2016/050323, has been granted in the USA.
This marks Particle3D’s second patent issuance, following the approval and publication of its European patent, EP/3359318, in April 2020.
The patent covers the Company’s novel technology, which facilitates a new additive manufacturing process where medical implants are constructed directly from a computer-aided design (CAD) file. Particle3D will use this new way of 3D printing to enable the creation of P3D Bone, a unique patient specific implant with controlled internal voids and porosities, that allow for optimized bone ingrowth and a remodeling of the implant into real living bone.
The proprietary technology is currently used to produce and supply P3D Scaffolds, 3D printed bone models for in vitro and in vivo research wherein disease mechanisms can be studied and new treatments can be tested.
Particle3D is a Danish MedTech company founded on proprietary technology to 3D print patient-fitted, natural and degradable bone implants. This enables faster ingrowth on bone tissue, remodeling into real living bone, and results in fewer complications. The technology can also be used for 3D printed R&D products, implants with additives, such as antibiotics or other drugs, and even in industries outside healthcare. Website Particle3D – We Print Bone.